Table 2.
Multiple Analysis, Definitive Surgery and Receipt of Adjuvant Treatment Among Women With Breast Cancer Enrolleed in Medicaid in Georgia
| Variable | Lumpectomy Versus Mastectomy (n = 1,387) | Lumpectomy With Versus Without Radiation (n = 479) | Mastectomy and Follow-Up (n = 723) |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| One Versus None |
Two or More Versus None |
|||||||||||
| OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P | |
| Medicaid eligibility group | ||||||||||||
| BCCPTA | 1.42 | 0.96 to −2.10 | .080 | 1.56 | 0.77 to −3.17 | .218 | 1.81 | 0.78 to −4.19 | .167 | 2.70 | 1.20 to −6.10 | .017 |
| Disabled | 0.76 | 0.52 to −1.10 | .140 | 0.78 | 0.39 to −1.58 | .495 | 1.14 | 0.53 to −2.43 | .742 | 1.53 | 0.73 to −3.24 | .264 |
| Other | Ref. | Ref. | Ref. | Ref. | ||||||||
| Previously enrolled | 1.35 | 0.96 to −1.90 | .081 | 1.33 | 0.69 to −2.56 | .400 | 1.29 | 0.63 to −2.63 | .491 | 0.99 | 0.50 to −1.98 | .984 |
| Enrolled > 24 months | 0.93 | 0.74 to −1.18 | .549 | 0.55 | 0.35 to −0.87 | .010 | 1.18 | 0.70 to −2.01 | .535 | 1.45 | 0.87 to −2.41 | .157 |
| Age at Medicaid enrollment, years | ||||||||||||
| 19-44 | Ref. | Ref. | Ref. | Ref. | ||||||||
| 45-54 | 1.11 | 0.83 to −1.48 | .477 | 1.59 | 0.94 to −2.67 | .081 | 1.01 | 0.52 to −1.96 | .977 | 0.67 | 0.35 to −1.25 | .207 |
| 55-63 | 1.10 | 0.81 to −1.49 | .535 | 1.84 | 1.06 to −3.21 | .032 | 1.33 | 0.65 to −2.74 | .435 | 0.86 | 0.43 to −1.71 | .673 |
| Race/ethnicity | ||||||||||||
| White | Ref. | Ref. | Ref. | |||||||||
| Black | 0.86 | 0.67 to −1.10 | .239 | 0.99 | 0.64 to −1.55 | .981 | 2.09 | 1.17 to −3.73 | .013 | 2.04 | 1.17 to −3.56 | .012 |
| Other | 1.48 | 0.88 to −2.51 | .142 | 12.38 | 1.61 to −95.29 | .016 | 2.62 | 0.50 to −13.83 | .256 | 3.93 | 0.83 to −18.61 | .084 |
| Stage at diagnosis | ||||||||||||
| In situ | Ref. | — | — | — | — | — | — | — | — | — | ||
| Local | 0.67 | 0.47 to −0.94 | .021 | Ref. | Ref. | Ref. | ||||||
| Regional | 0.36 | 0.25 to −0.51 | < .001 | 1.07 | 0.70 to −1.63 | .759 | 1.48 | 0.86 to −2.53 | .157 | 0.33 | 0.19 to −0.54 | < .001 |
| Distant metastases | — | — | — | — | — | — | — | — | — | — | — | — |
| Comorbidity index | ||||||||||||
| 0 | Ref. | Ref. | Ref. | Ref. | ||||||||
| 1 | 0.87 | 0.67 to −1.14 | 0.319 | 1.21 | 0.73 to −2.03 | .457 | 1.02 | 0.54 to −1.93 | .956 | 1.35 | 0.73 to −2.49 | .339 |
| ≥ 2 | 0.78 | 0.57 to −1.09 | 0.143 | 0.83 | 0.46 to −1.50 | .536 | 1.11 | 0.54 to −2.28 | .769 | 1.19 | 0.59 to −2.37 | .630 |
| Resident county | ||||||||||||
| Central city, large metropolitan area | Ref. | Ref. | Ref. | Ref. | ||||||||
| Fringe county, large metropolitan area | 1.12 | 0.82 to −1.53 | 0.466 | 1.60 | 0.91 to −2.82 | .103 | 0.38 | 0.17 to −0.85 | .019 | 0.52 | 0.24 to −1.14 | .103 |
| Small metropolitan area | 0.72 | 0.50 to −1.04 | 0.079 | 1.64 | 0.82 to −3.29 | .162 | 0.59 | 0.25 to −1.36 | .214 | 0.72 | 0.32 to −1.63 | .435 |
| Completely rural | 1.02 | 0.54 to −1.93 | 0.953 | 0.61 | 0.20 to −1.80 | .369 | 0.57 | 0.12 to −2.73 | .486 | 0.57 | 0.13 to −2.57 | .465 |
| % Household income < $15K | 0.98 | 0.96 to −1.00 | 0.029 | 1.01 | 0.98 to −1.05 | .419 | 0.97 | 0.92 to −1.01 | .106 | 0.97 | 0.93 to −1.01 | .156 |
| With at least one oncology service hospital | 1.05 | 0.74 to −1.49 | 0.786 | 0.71 | 0.37 to −1.36 | .303 | 0.33 | 0.15 to −0.75 | .008 | 0.38 | 0.18 to −0.83 | .015 |
| With at least one CoC-approved hospital | 0.67 | 0.45 to −0.99 | 0.044 | 2.13 | 1.05 to −4.33 | .036 | 0.69 | 0.28 to −1.68 | .411 | 0.70 | 0.30 to −1.63 | .408 |
| Ob/Gyn per 1,000 women | 2.55 | 1.20 to −5.44 | 0.015 | 0.35 | 0.08 to −1.56 | .170 | 6.25 | 1.08 to −36.08 | .041 | 3.24 | 0.59 to −17.71 | .175 |
NOTE. Bold type indicates statistical significance. Dashes indicate data not reported.
Abbreviations: BCCPTA, Breast and Cervical Cancer Prevention and Treatment Act; CoC, Commission on Cancer; Ob/Gyn, obstetrician/gynecologist; OR, odds ratio; Ref., reference.